Anti-tumor targeting therapy using recombinant fusion proteins (RGD4C-yeast cytosine deaminase series) with 5-fluorocytosine
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 104
Main Authors: | Li-Chen Chen, 陳立宸 |
---|---|
Other Authors: | C. Allen Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/19557079618808475589 |
Similar Items
-
Anti-Tumor Therapy Mediated by 5-Fluorocytosine and a Recombinant Fusion Protein Containing human epidermal growth factor and Yeast Cytosine Deaminase
by: Hao-Qun Lin, et al.
Published: (2013) -
Biological characterizations of Tumor-targeting Fusion Proteins-NGR-Cytosine Deaminase and RGD-hEGF-against Tumor and Angiogenesis
by: Wei-Cheng Juan, et al.
Published: (2015) -
Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
by: Yuedi Ding, et al.
Published: (2020-06-01) -
Adenovirus-mediated interleukin-12 gene transfer combined with <it>cytosine deaminase </it>followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice
by: Kim Samyong, et al.
Published: (2005-05-01) -
Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo
by: Xiao-Ping Yang, et al.
Published: (2015-01-01)